A carregar...
O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions
Glioblastoma (GBM) is the most malignant type of primary brain tumor with a very poor prognosis. The actual standard protocol of treatment for GBM patients consists of radiotherapy and concomitant temozolomide (TMZ). However, the therapeutic efficacy of this treatment is limited due to tumor recurre...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Molecular Diversity Preservation International (MDPI)
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3397507/ https://ncbi.nlm.nih.gov/pubmed/22837675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms13066983 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|